APPLIED THERAPEUTICS INC (APLT) Stock Balance Sheet
NASDAQ:APLT - Nasdaq - US03828A1016 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 50.76M | 79.40M | 49.90M | 16.70M | 53.90M | |||
| Marketable Securities | N/A | 0.00 | 254.00K | 13.90M | 26.90M | |||
| Other Current Assets | 3.20M | 4.25M | 4.23M | 6.70M | 7.60M | |||
| Total Current Assets | 53.97M | 83.65M | 54.39M | 37.30M | 88.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.69M | 2.79M | 447.00K | 900.00K | 1.30M | |||
| Other Non-Current Assets | 253.00K | 253.00K | 0.00 | 200.00K | 200.00K | |||
| Total Non-Current Assets | 2.94M | 3.04M | 447.00K | 1.10M | 1.50M | |||
| TOTAL ASSETS | 56.91M | 86.69M | 54.83M | 38.40M | 89.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.24M | 15.73M | 15.05M | 15.20M | 16.00M | |||
| Accounts Payable | 4.87M | 4.43M | 1.74M | 4.50M | 9.50M | |||
| Other Current Liabilities | 3.86M | 7.13M | 54.39M | 13.70M | 1.00M | |||
| Total Current Liabilities | 17.96M | 27.30M | 71.18M | 33.40M | 26.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.27M | 2.39M | 797.00K | 900.00K | 900.00K | |||
| Total Non-Current Liabilities | 2.27M | 2.39M | 797.00K | 900.00K | 900.00K | |||
| TOTAL LIABILITIES | 20.24M | 29.68M | 71.98M | 34.30M | 27.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -596.03M | -574.21M | -468.59M | -348.80M | -266.30M | |||
| Additional Paid In Capital | 632.67M | 631.18M | 451.43M | 352.80M | 329.00M | |||
| Common Shares | 35.00K | 35.00K | 8.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | 100.00K | -100.00K | |||
| Shares Outstanding | 141.58M | 137.23M | 84.87M | 48.10M | 26.20M | |||
| Tangible Book Value per Share | 0.26 | 0.42 | -0.20 | 0.09 | 2.39 | |||
| Total Shareholders' Equity | 36.67M | 57.01M | -17.15M | 4.10M | 62.50M | |||
| TOTAL LIABILITIES AND EQUITY | 56.91M | 86.69M | 54.83M | 38.40M | 89.90M | |||
| Statistics | ||||||||
| Current Ratio | 3.00 | 3.06 | 0.76 | 1.12 | 3.34 | |||
| Return On Assets (ROA) | -76.46% | -121.84% | -218.41% | -214.87% | -117.44% | |||
| Return On Equity (ROE) | -118.66% | -185.29% | N/A | -2012.44% | -168.93% | |||
All data in USD , ROIC based on taxRate of 0.21